Kornitzer Capital Management Inc. KS trimmed its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 5.2% in the third quarter, according to its most recent filing with the SEC. The fund owned 26,601 shares of the pharmacy operator’s stock after selling 1,460 shares during the period. Kornitzer Capital Management Inc. KS’s holdings in Walgreens Boots Alliance were worth $1,939,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds have also recently made changes to their positions in the company. BlackRock Inc. raised its position in Walgreens Boots Alliance by 1.5% during the 2nd quarter. BlackRock Inc. now owns 53,148,612 shares of the pharmacy operator’s stock worth $3,189,715,000 after purchasing an additional 771,307 shares during the last quarter. Franklin Resources Inc. raised its position in Walgreens Boots Alliance by 21.5% during the 3rd quarter. Franklin Resources Inc. now owns 18,789,390 shares of the pharmacy operator’s stock worth $1,369,796,000 after purchasing an additional 3,318,524 shares during the last quarter. Bank of New York Mellon Corp raised its position in Walgreens Boots Alliance by 71,970.7% during the 3rd quarter. Bank of New York Mellon Corp now owns 11,640,855 shares of the pharmacy operator’s stock worth $848,617,000 after purchasing an additional 11,624,703 shares during the last quarter. LSV Asset Management raised its position in Walgreens Boots Alliance by 28.5% during the 3rd quarter. LSV Asset Management now owns 11,183,914 shares of the pharmacy operator’s stock worth $815,307,000 after purchasing an additional 2,479,681 shares during the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec raised its position in Walgreens Boots Alliance by 11.5% during the 2nd quarter. Caisse DE Depot ET Placement DU Quebec now owns 11,110,617 shares of the pharmacy operator’s stock worth $666,804,000 after purchasing an additional 1,143,819 shares during the last quarter. Institutional investors own 62.59% of the company’s stock.
Shares of Walgreens Boots Alliance stock opened at $82.82 on Thursday. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.82 and a quick ratio of 0.38. Walgreens Boots Alliance Inc has a 1-year low of $59.07 and a 1-year high of $86.31. The stock has a market cap of $80.37 billion, a price-to-earnings ratio of 13.76, a price-to-earnings-growth ratio of 1.34 and a beta of 0.76.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, October 11th. The pharmacy operator reported $1.48 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.45 by $0.03. Walgreens Boots Alliance had a return on equity of 21.75% and a net margin of 3.82%. The firm had revenue of $33.44 billion during the quarter, compared to the consensus estimate of $33.64 billion. On average, sell-side analysts forecast that Walgreens Boots Alliance Inc will post 6.54 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 12th. Shareholders of record on Monday, November 12th will be issued a dividend of $0.44 per share. The ex-dividend date of this dividend is Thursday, November 8th. This represents a $1.76 dividend on an annualized basis and a yield of 2.13%. Walgreens Boots Alliance’s payout ratio is currently 29.24%.
Several research analysts recently issued reports on the company. Zacks Investment Research lowered Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research report on Monday. Robert W. Baird raised their target price on Walgreens Boots Alliance from $69.00 to $71.00 and gave the stock a “neutral” rating in a research report on Friday, October 12th. BidaskClub raised Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, August 21st. TheStreet raised Walgreens Boots Alliance from a “c+” rating to a “b” rating in a research report on Wednesday, September 12th. Finally, SunTrust Banks raised their target price on Walgreens Boots Alliance to $75.00 and gave the stock a “hold” rating in a research report on Friday, October 12th. One research analyst has rated the stock with a sell rating, twelve have issued a hold rating, six have assigned a buy rating and two have given a strong buy rating to the company’s stock. Walgreens Boots Alliance currently has a consensus rating of “Hold” and an average target price of $78.89.
In other Walgreens Boots Alliance news, EVP Kathleen Wilson-Thompson sold 52,000 shares of the stock in a transaction dated Wednesday, October 31st. The stock was sold at an average price of $78.77, for a total transaction of $4,096,040.00. Following the completion of the sale, the executive vice president now directly owns 81,076 shares in the company, valued at approximately $6,386,356.52. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Kimberly R. Scardino sold 11,970 shares of the firm’s stock in a transaction dated Thursday, November 1st. The shares were sold at an average price of $79.79, for a total value of $955,086.30. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 73,756 shares of company stock valued at $5,824,194. Company insiders own 14.80% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Kornitzer Capital Management Inc. KS Reduces Stake in Walgreens Boots Alliance Inc (WBA)” was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of US & international trademark & copyright law. The correct version of this report can be accessed at https://www.dispatchtribunal.com/2018/12/06/kornitzer-capital-management-inc-ks-reduces-stake-in-walgreens-boots-alliance-inc-wba.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Article: How is an ETF different from a mutual fund?
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.